{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:19:28Z","timestamp":1793495968971,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41380-026-03558-8","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:12:43Z","timestamp":1774696363000},"page":"4463-4474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Brain structural abnormalities in treatment-resistant schizophrenia"],"prefix":"10.1038","volume":"31","author":[{"given":"Semra","family":"Etyemez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Sivananthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1673-002X","authenticated-orcid":false,"given":"Andreia V.","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7051-5013","authenticated-orcid":false,"given":"Felice","family":"Iasevoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pontillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabella","family":"Di Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9491-1822","authenticated-orcid":false,"given":"Young-Chul","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyolsaikhan","family":"Odkhuu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1060-1462","authenticated-orcid":false,"given":"Jun Soo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8668-0817","authenticated-orcid":false,"given":"Minah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minji","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8784-9653","authenticated-orcid":false,"given":"Foivos","family":"Georgiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5064-6385","authenticated-orcid":false,"given":"Beatrice A.","family":"Milano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9486-1439","authenticated-orcid":false,"given":"Matthias","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1458-3932","authenticated-orcid":false,"given":"Diana","family":"Tordesillas-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3209-9626","authenticated-orcid":false,"given":"Kang","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3522-3912","authenticated-orcid":false,"given":"Yunlong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry Kit Wa","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0076-8434","authenticated-orcid":false,"given":"Jessica A.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo G. M.","family":"van Erp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7724-7445","authenticated-orcid":false,"given":"Jimmy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9058-0747","authenticated-orcid":false,"given":"Vince D.","family":"Calhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1401-3008","authenticated-orcid":false,"given":"Akira","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1060-8082","authenticated-orcid":false,"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"3558_CR1","doi-asserted-by":"publisher","first-page":"e0234121","DOI":"10.1371\/journal.pone.0234121","volume":"15","author":"MF M\u00f8rup","year":"2020","unstructured":"M\u00f8rup MF, Kymes SM, Oudin \u00c5str\u00f6m D. A modelling approach to estimate the prevalence of treatment-resistant schizophrenia in the United States. PLoS One. 2020;15:e0234121.","journal-title":"PLoS One"},{"key":"3558_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1192\/bjp.2021.61","volume":"220","author":"D Siskind","year":"2022","unstructured":"Siskind D, Orr S, Sinha S, Yu O, Brijball B, Warren N, et al. Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis. Br J Psychiatry. 2022;220:115\u201320.","journal-title":"Br J Psychiatry"},{"key":"3558_CR3","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1177\/0269881119855995","volume":"33","author":"K Beck","year":"2019","unstructured":"Beck K, McCutcheon R, Stephenson L, Schilderman M, Patel N, Ramsay R, et al. Prevalence of treatment-resistant psychoses in the community: A naturalistic study. J Psychopharmacol. 2019;33:1248\u201353.","journal-title":"J Psychopharmacol"},{"key":"3558_CR4","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/s41380-021-01331-7","volume":"27","author":"K Yang","year":"2022","unstructured":"Yang K, Longo L, Narita Z, Cascella N, Nucifora FC, Coughlin JM, et al. A multimodal study of a first episode psychosis cohort: potential markers of antipsychotic treatment resistance. Mol Psychiatry. 2022;27:1184\u201391.","journal-title":"Mol Psychiatry"},{"key":"3558_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/schbul\/sbaa145","volume":"47","author":"SKW Chan","year":"2021","unstructured":"Chan SKW, Chan HYV, Honer WG, Bastiampillai T, Suen YN, Yeung WS, et al. Predictors of treatment-resistant and clozapine-resistant schizophrenia: A 12-year follow-up study of first-episode schizophrenia-spectrum disorders. Schizophr Bull. 2021;47:485\u201394.","journal-title":"Schizophr Bull"},{"key":"3558_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s13311-017-0552-9","volume":"14","author":"FC Nucifora","year":"2017","unstructured":"Nucifora FC, Mihaljevic M, Lee BJ, Sawa A. Clozapine as a model for antipsychotic development. Neurotherapeutics. 2017;14:750\u201361.","journal-title":"Neurotherapeutics."},{"key":"3558_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/mp.2017.214","volume":"23","author":"SE Legge","year":"2018","unstructured":"Legge SE, Hamshere ML, Ripke S, Pardinas AF, Goldstein JI, Rees E, et al. Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia. Mol Psychiatry. 2018;23:162\u20133.","journal-title":"Mol Psychiatry"},{"key":"3558_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S2215-0366(24)00136-6","volume":"11","author":"NH Salahuddin","year":"2024","unstructured":"Salahuddin NH, Sch\u00fctz A, Pitschel-Walz G, Mayer SF, Chaimani A, Siafis S, et al. Psychological and psychosocial interventions for treatment-resistant schizophrenia: a systematic review and network meta-analysis. Lancet Psychiatry. 2024;11:545\u201353.","journal-title":"Lancet Psychiatry"},{"key":"3558_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/jnnp-2017-316946","volume":"89","author":"JM Gault","year":"2018","unstructured":"Gault JM, Davis R, Cascella NG, Saks ER, Corripio-Collado I, Anderson WS, et al. Approaches to neuromodulation for schizophrenia. J Neurol Neurosurg Psychiatry. 2018;89:777\u201387.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3558_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/schbul\/17.2.247","volume":"17","author":"A Safferman","year":"1991","unstructured":"Safferman A, Lieberman JA, Kane JM, Szymanski S, Kinon B. Update on the clinical efficacy and side effects of clozapine. Schizophr Bull. 1991;17:247\u201361.","journal-title":"Schizophr Bull"},{"key":"3558_CR11","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3389\/fpsyt.2018.00757","volume":"9","author":"BJ Kinon","year":"2018","unstructured":"Kinon BJ. The group of treatment resistant schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS). Front Psychiatry. 2018;9:757.","journal-title":"Front Psychiatry"},{"key":"3558_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.psychres.2018.06.070","volume":"268","author":"P Shah","year":"2018","unstructured":"Shah P, Iwata Y, Plitman E, Brown EE, Caravaggio F, Kim J, et al. The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review. Psychiatry Res. 2018;268:114\u201322.","journal-title":"Psychiatry Res"},{"key":"3558_CR13","doi-asserted-by":"publisher","first-page":"104257","DOI":"10.1016\/j.nbd.2018.08.016","volume":"131","author":"FC Nucifora","year":"2019","unstructured":"Nucifora FC, Woznica E, Lee BJ, Cascella N, Sawa A. Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives. Neurobiol Dis. 2019;131:104257.","journal-title":"Neurobiol Dis"},{"key":"3558_CR14","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1017\/S0033291717000435","volume":"47","author":"A Demjaha","year":"2017","unstructured":"Demjaha A, Lappin JM, Stahl D, Patel MX, MacCabe JH, Howes OD, et al. Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors. Psychol Med. 2017;47:1981\u20139.","journal-title":"Psychol Med"},{"key":"3558_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-018-1853-1","volume":"18","author":"N Kanahara","year":"2018","unstructured":"Kanahara N, Yamanaka H, Suzuki T, Takase M, Iyo M. First-episode psychosis in treatment-resistant schizophrenia: a cross-sectional study of a long-term follow-up cohort. BMC Psychiatry. 2018;18:274.","journal-title":"BMC Psychiatry"},{"key":"3558_CR16","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1017\/S0033291716002014","volume":"46","author":"J Lally","year":"2016","unstructured":"Lally J, Ajnakina O, Di Forti M, Trotta A, Demjaha A, Kolliakou A, et al. Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses. Psychol Med. 2016;46:3231\u201340.","journal-title":"Psychol Med"},{"key":"3558_CR17","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S2215-0366(23)00109-8","volume":"10","author":"JJ Luykx","year":"2023","unstructured":"Luykx JJ, Gonzalez-Diaz JM, Guu T-W, van der Horst MZ, van Dellen E, Boks MP, et al. An international research agenda for clozapine-resistant schizophrenia. Lancet Psychiatry. 2023;10:644\u201352.","journal-title":"Lancet Psychiatry"},{"key":"3558_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02754-w","volume":"14","author":"TY Wong","year":"2024","unstructured":"Wong TY, Luo H, Tang J, Moore TM, Gur RC, Suen YN, et al. Development of an individualized risk calculator of treatment resistance in patients with first-episode psychosis (TRipCal) using automated machine learning: a 12-year follow-up study with clozapine prescription as a proxy indicator. Transl Psychiatry. 2024;14:50.","journal-title":"Transl Psychiatry"},{"key":"3558_CR19","doi-asserted-by":"publisher","first-page":"115985","DOI":"10.1016\/j.psychres.2024.115985","volume":"337","author":"SKW Chan","year":"2024","unstructured":"Chan SKW, Pang TSW, Tsui HKH, Suen YN, Yan WC, Tsui CF, et al. Modeling the effects of treatment resistance and anticholinergic burden on cognitive function domains in patients with schizophrenia. Psychiatry Res. 2024;337:115985.","journal-title":"Psychiatry Res"},{"key":"3558_CR20","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1038\/s41380-023-01969-5","volume":"28","author":"M Wang","year":"2023","unstructured":"Wang M, Barker PB, Cascella NG, Coughlin JM, Nestadt G, Nucifora FC, et al. Longitudinal changes in brain metabolites in healthy controls and patients with first episode psychosis: a 7-Tesla MRS study. Mol Psychiatry. 2023;28:2018\u201329.","journal-title":"Mol Psychiatry"},{"key":"3558_CR21","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3390\/antiox10111703","volume":"10","author":"L Palaniyappan","year":"2021","unstructured":"Palaniyappan L, Park MTM, Jeon P, Limongi R, Yang K, Sawa A, et al. Is there a glutathione centered redox dysregulation subtype of schizophrenia? Antioxidants (Basel). 2021;10:1703.","journal-title":"Antioxidants (Basel)"},{"key":"3558_CR22","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41380-020-0704-x","volume":"25","author":"K Dempster","year":"2020","unstructured":"Dempster K, Jeon P, MacKinley M, Williamson P, Th\u00e9berge J, Palaniyappan L. Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate. Mol Psychiatry. 2020;25:1640\u201350.","journal-title":"Mol Psychiatry"},{"key":"3558_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41537-023-00392-7","volume":"9","author":"TSW Pang","year":"2023","unstructured":"Pang TSW, Chun JSW, Wong TY, Chu ST, Ma CF, Honer WG, et al. A systematic review of neuroimaging studies of clozapine-resistant schizophrenia. Schizophrenia (Heidelb). 2023;9:65.","journal-title":"Schizophrenia (Heidelb)"},{"key":"3558_CR24","doi-asserted-by":"publisher","first-page":"pyv016","DOI":"10.1093\/ijnp\/pyv016","volume":"18","author":"VM Anderson","year":"2015","unstructured":"Anderson VM, Goldstein ME, Kydd RR, Russell BR. Extensive gray matter volume reduction in treatment-resistant schizophrenia. Int J Neuropsychopharmacol. 2015;18:pyv016.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3558_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S2215-0366(15)00540-4","volume":"3","author":"E Mouchlianitis","year":"2016","unstructured":"Mouchlianitis E, McCutcheon R, Howes OD. Brain-imaging studies of treatment-resistant schizophrenia: a systematic review. Lancet Psychiatry. 2016;3:451\u201363.","journal-title":"Lancet Psychiatry"},{"key":"3558_CR26","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1176\/appi.ajp.2019.18101212","volume":"176","author":"P Kochunov","year":"2019","unstructured":"Kochunov P, Huang J, Chen S, Li Y, Tan S, Fan F, et al. White matter in schizophrenia treatment resistance. Am J Psychiatry. 2019;176:829\u201338.","journal-title":"Am J Psychiatry"},{"key":"3558_CR27","doi-asserted-by":"publisher","first-page":"111043","DOI":"10.1016\/j.pscychresns.2020.111043","volume":"297","author":"J Huang","year":"2020","unstructured":"Huang J, Zhu Y, Fan F, Chen S, Hong Y, Cui Y, et al. Hippocampus and cognitive domain deficits in treatment-resistant schizophrenia: a comparison with matched treatment-responsive patients and healthy controls. Psychiatry Res Neuroimaging. 2020;297:111043.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"3558_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41537-022-00230-2","volume":"8","author":"F Krajner","year":"2022","unstructured":"Krajner F, Hadaya L, McQueen G, Sendt K-V, Gillespie A, Avila A, et al. Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia. Schizophrenia (Heidelb). 2022;8:13.","journal-title":"Schizophrenia (Heidelb)"},{"key":"3558_CR29","doi-asserted-by":"publisher","first-page":"1042814","DOI":"10.3389\/fnins.2022.1042814","volume":"16","author":"M Dabiri","year":"2022","unstructured":"Dabiri M, Dehghani Firouzabadi F, Yang K, Barker PB, Lee RR, Yousem DM. Neuroimaging in schizophrenia: a review article. Front Neurosci. 2022;16:1042814.","journal-title":"Front Neurosci"},{"key":"3558_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S2215-0366(15)00575-1","volume":"3","author":"T Wimberley","year":"2016","unstructured":"Wimberley T, St\u00f8vring H, S\u00f8rensen HJ, Horsdal HT, MacCabe JH, Gasse C. Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study. Lancet Psychiatry. 2016;3:358\u201366.","journal-title":"Lancet Psychiatry"},{"key":"3558_CR31","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.6061\/clinics\/2012(12)20","volume":"67","author":"M Kayo","year":"2012","unstructured":"Kayo M, Tassell I, Hiroce V, Menezes A, Elkis H. Does lack of improvement in the first two weeks predict treatment resistance in recent-onset psychosis? Clinics (Sao Paulo). 2012;67:1479\u201382.","journal-title":"Clinics (Sao Paulo)"},{"key":"3558_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","volume":"174","author":"OD Howes","year":"2017","unstructured":"Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJM, Birnbaum ML, et al. Treatment-Resistant schizophrenia: Treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry. 2017;174:216\u201329.","journal-title":"Am J Psychiatry"},{"key":"3558_CR33","doi-asserted-by":"publisher","first-page":"MY20096AH1C","DOI":"10.4088\/JCP.MY20096AH1C","volume":"82","author":"CU Correll","year":"2021","unstructured":"Correll CU, Howes OD. Treatment-Resistant schizophrenia: definition, predictors, and therapy options. J Clin Psychiatry. 2021;82:MY20096AH1C.","journal-title":"J Clin Psychiatry"},{"key":"3558_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S2215-0366(25)00001-X","volume":"12","author":"J Schneider-Thoma","year":"2025","unstructured":"Schneider-Thoma J, Hamza T, Chalkou K, Siafis S, Dong S, Bighelli I, et al. Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysis. Lancet Psychiatry. 2025;12:254\u201365.","journal-title":"Lancet Psychiatry"},{"key":"3558_CR35","doi-asserted-by":"publisher","first-page":"18com12123","DOI":"10.4088\/JCP.18com12123","volume":"80","author":"JM Kane","year":"2019","unstructured":"Kane JM, Agid O, Baldwin ML, Howes O, Lindenmayer J-P, Marder S, et al. Clinical guidance on the identification and management of treatment-resistant schizophrenia. J Clin Psychiatry. 2019;80:18com12123.","journal-title":"J Clin Psychiatry"},{"key":"3558_CR36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/mp.2015.63","volume":"21","author":"TGM van Erp","year":"2016","unstructured":"van Erp TGM, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016;21:547\u201353.","journal-title":"Mol Psychiatry"},{"key":"3558_CR37","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.biopsych.2018.04.023","volume":"84","author":"TGM van Erp","year":"2018","unstructured":"van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, et al. Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta analysis (ENIGMA) consortium. Biol Psychiatry. 2018;84:644\u201354.","journal-title":"Biol Psychiatry"},{"key":"3558_CR38","doi-asserted-by":"publisher","first-page":"116956","DOI":"10.1016\/j.neuroimage.2020.116956","volume":"218","author":"J Radua","year":"2020","unstructured":"Radua J, Vieta E, Shinohara R, Kochunov P, Quid\u00e9 Y, Green MJ, et al. Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA. Neuroimage. 2020;218:116956.","journal-title":"Neuroimage."},{"key":"3558_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fninf.2018.00102","volume":"12","author":"PSW Boedhoe","year":"2018","unstructured":"Boedhoe PSW, Heymans MW, Schmaal L, Abe Y, Alonso P, Ameis SH, et al. An empirical comparison of meta- and mega-analysis with data from the ENIGMA obsessive-compulsive disorder working group. Front Neuroinform. 2018;12:102.","journal-title":"Front Neuroinform"},{"key":"3558_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/hipo.20873","volume":"22","author":"JJ Maller","year":"2012","unstructured":"Maller JJ, Daskalakis ZJ, Thomson RHS, Daigle M, Barr MS, Fitzgerald PB. Hippocampal volumetrics in treatment-resistant depression and schizophrenia: the devil\u2019s in de-tail. Hippocampus. 2012;22:9\u201316.","journal-title":"Hippocampus."},{"key":"3558_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/pcn.13486","volume":"77","author":"F Fan","year":"2023","unstructured":"Fan F, Huang J, Tan S, Wang Z, Li Y, Chen S, et al. Association of cortical thickness and cognition with schizophrenia treatment resistance. Psychiatry Clin Neurosci. 2023;77:12\u201319.","journal-title":"Psychiatry Clin Neurosci"},{"key":"3558_CR42","unstructured":"Kamalakannan SMV, Male AG, Yilan Li M, Lella A, Lee J, Quid\u00e9 Y, et al. Neuroanatomical Correlates of Negative Symptoms in Schizophrenia. bioRxiv: 2025.09.22.677864 [Preprint]. 2025 https:\/\/www.biorxiv.org\/content\/10.1101\/2025.09.22.677864v3."},{"key":"3558_CR43","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1001\/jamapsychiatry.2024.4534","volume":"82","author":"AR Pines","year":"2025","unstructured":"Pines AR, Frandsen SB, Drew W, Meyer GM, Howard C, Palm ST, et al. Mapping lesions that cause psychosis to a human brain circuit and proposed stimulation target. JAMA Psychiatry. 2025;82:368\u201378.","journal-title":"JAMA Psychiatry"},{"key":"3558_CR44","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/genes14030689","volume":"14","author":"J Ying","year":"2023","unstructured":"Ying J, Chew QH, McIntyre RS, Sim K. Treatment-Resistant schizophrenia, clozapine resistance, genetic associations, and implications for precision psychiatry: a scoping review. Genes (Basel). 2023;14:689.","journal-title":"Genes (Basel)"},{"key":"3558_CR45","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1017\/S0033291710002278","volume":"41","author":"A Di Giorgio","year":"2011","unstructured":"Di Giorgio A, Caforio G, Blasi G, Taurisano P, Fazio L, Romano R, et al. Catechol-O-methyltransferase Val(158)Met association with parahippocampal physiology during memory encoding in schizophrenia. Psychol Med. 2011;41:1721\u201331.","journal-title":"Psychol Med"},{"key":"3558_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.schres.2003.12.002","volume":"70","author":"E Antonova","year":"2004","unstructured":"Antonova E, Sharma T, Morris R, Kumari V. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res. 2004;70:117\u201345.","journal-title":"Schizophr Res"},{"key":"3558_CR47","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/npr2.12031","volume":"38","author":"S Nakahara","year":"2018","unstructured":"Nakahara S, Matsumoto M, van Erp TGM. Hippocampal subregion abnormalities in schizophrenia: A systematic review of structural and physiological imaging studies. Neuropsychopharmacol Rep. 2018;38:156\u201366.","journal-title":"Neuropsychopharmacol Rep"},{"key":"3558_CR48","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s13311-021-01174-8","volume":"19","author":"X Lang","year":"2022","unstructured":"Lang X, Wang D, Chen D, Xiu M, Zhou H, Wang L, et al. Association between hippocampal subfields and clinical symptoms of first-episode and drug naive schizophrenia patients during 12 weeks of risperidone treatment. Neurotherapeutics. 2022;19:399\u2013407.","journal-title":"Neurotherapeutics."},{"key":"3558_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/mp.2015.141","volume":"21","author":"MA Landek-Salgado","year":"2016","unstructured":"Landek-Salgado MA, Faust TE, Sawa A. Molecular substrates of schizophrenia: homeostatic signaling to connectivity. Mol Psychiatry. 2016;21:10\u201328.","journal-title":"Mol Psychiatry"},{"key":"3558_CR50","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/schbul\/sbz076","volume":"46","author":"EM Blessing","year":"2020","unstructured":"Blessing EM, Murty VP, Zeng B, Wang J, Davachi L, Goff DC. Anterior hippocampal-cortical functional connectivity distinguishes antipsychotic na\u00efve first-episode psychosis patients from controls and may predict response to second-generation antipsychotic treatment. Schizophr Bull. 2020;46:680\u20139.","journal-title":"Schizophr Bull"},{"key":"3558_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02108-9","volume":"8","author":"M Tamura","year":"2017","unstructured":"Tamura M, Spellman TJ, Rosen AM, Gogos JA, Gordon JA. Hippocampal-prefrontal theta-gamma coupling during performance of a spatial working memory task. Nat Commun. 2017;8:2182.","journal-title":"Nat Commun"},{"key":"3558_CR52","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nature08855","volume":"464","author":"T Sigurdsson","year":"2010","unstructured":"Sigurdsson T, Stark KL, Karayiorgou M, Gogos JA, Gordon JA. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature. 2010;464:763\u20137.","journal-title":"Nature."},{"key":"3558_CR53","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1523\/JNEUROSCI.2739-18.2019","volume":"39","author":"X-L Bian","year":"2019","unstructured":"Bian X-L, Qin C, Cai C-Y, Zhou Y, Tao Y, Lin Y-H, et al. Anterior cingulate cortex to ventral hippocampus circuit mediates contextual fear generalization. J Neurosci. 2019;39:5728\u201339.","journal-title":"J Neurosci"},{"key":"3558_CR54","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1101\/lm.053440.121","volume":"29","author":"T Nagayoshi","year":"2022","unstructured":"Nagayoshi T, Ishikawa R, Kida S. Anterior cingulate cortex projections to the dorsal hippocampus positively control the expression of contextual fear generalization. Learn Mem. 2022;29:77\u201382.","journal-title":"Learn Mem"},{"key":"3558_CR55","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1093\/cercor\/bhaa333","volume":"31","author":"J Wang","year":"2021","unstructured":"Wang J, John Y, Barbas H. Pathways for contextual memory: the primate hippocampal pathway to anterior cingulate cortex. Cereb Cortex. 2021;31:1807\u201326.","journal-title":"Cereb Cortex"},{"key":"3558_CR56","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0006-3223(01)01267-7","volume":"50","author":"C Konradi","year":"2001","unstructured":"Konradi C, Heckers S. Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biol Psychiatry. 2001;50:729\u201342.","journal-title":"Biol Psychiatry"},{"key":"3558_CR57","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neubiorev.2015.11.008","volume":"60","author":"W Rief","year":"2016","unstructured":"Rief W, Barsky AJ, Bingel U, Doering BK, Schwarting R, W\u00f6hr M, et al. Rethinking psychopharmacotherapy: The role of treatment context and brain plasticity in antidepressant and antipsychotic interventions. Neurosci Biobehav Rev. 2016;60:51\u201364.","journal-title":"Neurosci Biobehav Rev"},{"key":"3558_CR58","doi-asserted-by":"publisher","first-page":"119768","DOI":"10.1016\/j.neuroimage.2022.119768","volume":"264","author":"P Parekh","year":"2022","unstructured":"Parekh P, Vivek Bhalerao G, ADBS consortium, John JP, Venkatasubramanian G. Sample size requirement for achieving multisite harmonization using structural brain MRI features. Neuroimage. 2022;264:119768.","journal-title":"Neuroimage."},{"key":"3558_CR59","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1001\/jamapsychiatry.2021.3799","volume":"79","author":"AF Pardi\u00f1as","year":"2022","unstructured":"Pardi\u00f1as AF, Smart SE, Willcocks IR, Holmans PA, Dennison CA, Lynham AJ, et al. Interaction testing and polygenic risk scoring to estimate the association of common genetic variants with treatment resistance in schizophrenia. JAMA Psychiatry. 2022;79:260\u20139.","journal-title":"JAMA Psychiatry"},{"key":"3558_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-024-00673-x","volume":"18","author":"H\u00c7 Lenk","year":"2024","unstructured":"Lenk H\u00c7, Koch E, O\u2019Connell KS, Smith RL, Akkouh IA, Djurovic S, et al. Genome-wide association analysis of treatment resistant schizophrenia for variant discovery and polygenic assessment. Hum Genomics. 2024;18:108.","journal-title":"Hum Genomics"},{"key":"3558_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-29117-7","volume":"13","author":"AT Kopylov","year":"2023","unstructured":"Kopylov AT, Stepanov AA, Butkova TV, Malsagova KA, Zakharova NV, Kostyuk GP, et al. Consolidation of metabolomic, proteomic, and GWAS data in connective model of schizophrenia. Sci Rep. 2023;13:2139.","journal-title":"Sci Rep"},{"key":"3558_CR62","doi-asserted-by":"publisher","first-page":"sgab032","DOI":"10.1093\/schizbullopen\/sgab032","volume":"2","author":"JO Maximo","year":"2021","unstructured":"Maximo JO, Kraguljac NV, Rountree BG, Lahti AC. Structural and functional default mode network connectivity and antipsychotic treatment response in medication-na\u00efve first episode psychosis patients. Schizophr Bull Open. 2021;2:sgab032.","journal-title":"Schizophr Bull Open"},{"key":"3558_CR63","doi-asserted-by":"publisher","first-page":"1127508","DOI":"10.3389\/fnimg.2023.1127508","volume":"2","author":"N Tuovinen","year":"2023","unstructured":"Tuovinen N, Hofer A. Resting-state functional MRI in treatment-resistant schizophrenia. Front Neuroimaging. 2023;2:1127508.","journal-title":"Front Neuroimaging"},{"key":"3558_CR64","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/brain\/awaa025","volume":"143","author":"GB Chand","year":"2020","unstructured":"Chand GB, Dwyer DB, Erus G, Sotiras A, Varol E, Srinivasan D, et al. Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning. Brain. 2020;143:1027\u201338.","journal-title":"Brain."}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03558-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03558-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03558-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:02:19Z","timestamp":1783926139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03558-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3558"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03558-8","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}